AOD-9604 is tracked as a US research-market identity, not as an authorization or local supply finding for Australia.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
AOD-9604 is tracked as a US research-market identity, not as an authorization or local supply finding for Australia. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Resolve the exact identity of AOD-9604 through Read the FDA source from U.S. Food and Drug Administration. Then search Searching the Australian Register of Therapeutic Goods from Therapeutic Goods Administration for the destination product record and Personal Importation Scheme from Therapeutic Goods Administration for the seller, establishment, or supply route in Australia. A match in one record does not replace the other two checks.
No. A page using the name AOD-9604, local currency, a domestic delivery claim, or a familiar package image is only a lead. AOD-9604 reached controlled human studies, but the largest oral obesity trial did not show a statistically significant weight-loss difference and the sponsor terminated development for obesity. FDA states that neither AOD-9604 free base nor acetate is a component of an approved drug. Current seller-labelled 5 mg research vials do not inherit the identity, route, formulation, manufacturing record, or monitoring of the historical trial products. For Australia, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
AOD-9604 is tracked as a US research-market identity, not as an authorization or local supply finding for Australia. Match the exact category, legal seller identity, and claimed route against the official records on this page.
Primary identity source: Read the FDA source / U.S. Food and Drug Administration ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Read the FDA source is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Read the FDA source ↗Searching the Australian Register of Therapeutic Goods is maintained by Therapeutic Goods Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Searching the Australian Register of Therapeutic Goods ↗Personal Importation Scheme is maintained by Therapeutic Goods Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Personal Importation Scheme ↗Australian search results can combine therapeutic goods on the ARTG, practitioner or pharmacy services, conditional personal-import routes, and laboratory suppliers. Those categories answer different regulatory questions and should not share one price ranking.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Check the product, sponsor, ingredient, and ARTG identifier in the TGA database; goods not included generally cannot be supplied unless an exemption or access pathway applies.
Use Ahpra’s public register to match the person, profession, current registration status, and state instead of relying on a clinic biography.
Personal importation has quantity and eligibility conditions, and the TGA states imported products have not been evaluated for safety, quality, or efficacy.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.